Annual Accounts Receivable:
$65.48M+$11.96M(+22.35%)Summary
- As of today, CPRX annual accounts receivable is $65.48 million, with the most recent change of +$11.96 million (+22.35%) on December 31, 2024.
- During the last 3 years, CPRX annual accounts receivable has risen by +$58.86 million (+889.21%).
- CPRX annual accounts receivable is now at all-time high.
Performance
CPRX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$65.86M-$5.40M(-7.58%)Summary
- As of today, CPRX quarterly accounts receivable is $65.86 million, with the most recent change of -$5.40 million (-7.58%) on June 30, 2025.
- Over the past year, CPRX quarterly accounts receivable has increased by +$8.69 million (+15.20%).
- CPRX quarterly accounts receivable is now -7.58% below its all-time high of $71.27 million, reached on March 31, 2025.
Performance
CPRX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CPRX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +22.4% | +15.2% |
| 3Y3 Years | +889.2% | +587.0% |
| 5Y5 Years | +521.4% | +874.0% |
CPRX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +889.2% | -7.6% | +605.4% |
| 5Y | 5-Year | at high | +993.6% | -7.6% | +1075.9% |
| All-Time | All-Time | at high | >+9999.0% | -7.6% | >+9999.0% |
CPRX Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $65.86M(-7.6%) |
| Mar 2025 | - | $71.27M(+8.8%) |
| Dec 2024 | $65.48M(+22.4%) | $65.48M(+12.4%) |
| Sep 2024 | - | $58.27M(+1.9%) |
| Jun 2024 | - | $57.17M(-5.5%) |
| Mar 2024 | - | $60.49M(+13.0%) |
| Dec 2023 | $53.51M(+412.6%) | $53.51M(+11.4%) |
| Sep 2023 | - | $48.05M(+12.3%) |
| Jun 2023 | - | $42.80M(+28.1%) |
| Mar 2023 | - | $33.40M(+220.0%) |
| Dec 2022 | $10.44M(+57.7%) | $10.44M(+11.8%) |
| Sep 2022 | - | $9.34M(-2.6%) |
| Jun 2022 | - | $9.59M(-9.1%) |
| Mar 2022 | - | $10.55M(+59.4%) |
| Dec 2021 | $6.62M | $6.62M(-0.1%) |
| Sep 2021 | - | $6.63M(+5.3%) |
| Jun 2021 | - | $6.29M(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $5.60M(-6.5%) |
| Dec 2020 | $5.99M(-43.2%) | $5.99M(+2.0%) |
| Sep 2020 | - | $5.87M(-13.2%) |
| Jun 2020 | - | $6.76M(-2.3%) |
| Mar 2020 | - | $6.92M(-34.3%) |
| Dec 2019 | $10.54M(>+9900.0%) | $10.54M(+4.4%) |
| Sep 2019 | - | $10.10M(-2.7%) |
| Jun 2019 | - | $10.38M(+43.1%) |
| Mar 2019 | - | $7.25M(>+9900.0%) |
| Dec 2018 | - | $0.00 |
| Dec 2010 | $0.00(0.0%) | - |
| Dec 2009 | $0.00(0.0%) | - |
| Dec 2008 | $0.00(0.0%) | - |
| Dec 2007 | $0.00(0.0%) | - |
| Dec 2006 | $0.00(0.0%) | - |
| Dec 2005 | $0.00(0.0%) | - |
| Dec 2004 | $0.00 | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual accounts receivable?
The current annual accounts receivable of CPRX is $65.48M
What is the all-time high annual accounts receivable for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual accounts receivable is $65.48M
What is Catalyst Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
Over the past year, CPRX annual accounts receivable has changed by +$11.96M (+22.35%)
What is Catalyst Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of CPRX is $65.86M
What is the all-time high quarterly accounts receivable for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $71.27M
What is Catalyst Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
Over the past year, CPRX quarterly accounts receivable has changed by +$8.69M (+15.20%)